無水晶体症の世界市場規模、シェア、成長分析：タイプ別、エンドユーザー別、治療法別、地域別 - 産業予測（2025年～2032年）

世界の無水晶体症の市場規模は、2023年に18億米ドルとなり、予測期間（2025年～2032年）のCAGRは11.3%で、2024年の20億米ドルから2032年には47億2,000万米ドルに成長する見通しです。

世界の無水晶体症市場は、白内障患者の増加、高齢者人口の拡大、眼外傷の罹患率の上昇により大きな成長を遂げています。事故やスポーツによる眼外傷の蔓延は、しばしばレンズの脱臼を引き起こし、市場拡大をさらに促進します。レンズ設計の革新は視力矯正を強化し、無水晶体症治療の採用拡大につながります。さらに、目の健康と早期介入の重要性に対する意識の高まりが市場の需要を押し上げています。様々な取り組みによるヘルスケアへのアクセスの向上は、治療の機会を広げます。AI、機械学習、IoT、拡張現実（AR）、仮想現実（VR）などの技術的進歩は、高度な患者モニタリング、手術ガイダンス、診断能力の強化を可能にすることで市場に革命をもたらし、それによって世界的に患者とヘルスケア提供者の両方の治療成績を向上させています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別の機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ

無水晶体症の市場規模：タイプ別、CAGR（2025年～2032年）

• 市場概要
• 後天性無水晶体症
• 先天性無水晶体症

無水晶体症の市場規模：エンドユーザー別、CAGR（2025年～2032年）

• 市場概要
• 病院
• 眼科クリニック
• その他

無水晶体症の市場規模：治療法別、CAGR（2025年～2032年）

• 市場概要
• 眼鏡
• コンタクトレンズ
• 眼内レンズ挿入術
• 屈折矯正手術

無水晶体症市場規模、CAGR（2025年～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比の比較（2022年～2024年）

主要企業プロファイル

• Johnson & Johnson Vision（Johnson & Johnson Services Inc.）
• Alcon Laboratories Inc.
• Carl Zeiss AG（ZEISS International）
• Bausch+Lomb Incorporated
• Rayner Intraocular Lenses Limited
• Ophtec BV
• CooperVision Inc.
• Hoya Corporation
• Menicon Co. Ltd.
• Bohus BioTech AB
• Lifecore Biomedical, LLC
• Mediphacos
• Santen Pharmaceutical Co. Ltd.
• UltraVision CLPL

結論と提言

Global Aphakia Market size was valued at USD 1.8 billion in 2023 and is poised to grow from USD 2.0 billion in 2024 to USD 4.72 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The global aphakia market is experiencing significant growth due to a rise in cataract cases, an increasing aging population, and a heightened incidence of eye trauma. The prevalence of eye injuries from accidents and sports often results in lens dislocation, further driving market expansion. Innovations in lens design enhance visual correction, leading to greater adoption of aphakia treatments. Moreover, heightened awareness about eye health and the importance of early intervention boosts market demand. Improved healthcare access through various initiatives fosters widespread treatment opportunities. Technological advancements, including AI, machine learning, IoT, augmented reality, and virtual reality, are revolutionizing the market by enabling sophisticated patient monitoring, surgical guidance, and enhanced diagnostic capabilities, thereby improving outcomes for both patients and healthcare providers globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aphakia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aphakia Market Segments Analysis

Global Aphakia Market is segmented by Type, End User, Treatment and region. Based on Type, the market is segmented into Acquired Aphakia and Congenital Aphakia. Based on End User, the market is segmented into Hospitals, Ophthalmic clinics and Others. Based on Treatment, the market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation and Refractive Surgery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aphakia Market

The global aphakia market is significantly driven by the rising demand for cataract surgeries, which involve the removal of the natural lens from the eye, creating avenues for effective aphakia treatments. As more healthcare professionals prefer surgeries for high-risk cataract patients, the market experiences enhanced growth potential. Furthermore, regions with improved healthcare access are witnessing a surge in aphakia cases, further propelling market expansion. This combination of surgical advancements and increased patient accessibility underscores the robust opportunities for innovation and investment within the aphakia treatment sector on a global scale.

Restraints in the Global Aphakia Market

The global aphakia market faces significant constraints primarily due to the high costs associated with treatment options. Interventions typically involve the use of intraocular lenses, specialized contact lenses, or intricate surgical procedures, all of which can be prohibitively expensive. This financial burden limits access and hinders the adoption of effective therapies for those affected by aphakia. Furthermore, manufacturers encounter difficulties in balancing affordability with the necessary standards of precision and safety, which further complicates efforts to enhance market availability and treatment accessibility. Consequently, these factors collectively contribute to the restricted growth of the aphakia treatment market.

Market Trends of the Global Aphakia Market

The Global Aphakia market is witnessing a significant trend driven by the escalating demand for intraocular lenses (IOLs) as patients and ophthalmologists increasingly recognize their advantages in correcting vision. This surge is further propelled by a broader shift towards minimally invasive surgical techniques, which enhance patient comfort and recovery. As advancements in IOL technology continue to emerge, offering improved visual outcomes and reduced complications, more individuals are opting for these solutions post-cataract surgery. The combination of heightened awareness, technological innovations, and a preference for efficient surgical processes is collectively fostering a robust growth trajectory in the Global Aphakia market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Aphakia Market Size by Type & CAGR (2025-2032)

• Market Overview
• Acquired Aphakia
• Congenital Aphakia

Global Aphakia Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ophthalmic clinics
• Others

Global Aphakia Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Spectacles
• Contact Lenses
• Intraocular Lens Implantation
• Refractive Surgery

Global Aphakia Market Size & CAGR (2025-2032)

• North America (Type, End User, Treatment)
  • US
  • Canada
• Europe (Type, End User, Treatment)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, End User, Treatment)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, End User, Treatment)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, End User, Treatment)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson Vision (Johnson & Johnson Services Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG (ZEISS International)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayner Intraocular Lenses Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ophtec BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperVision Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menicon Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus BioTech AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UltraVision CLPL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations